Cognitive function prior to systemic therapy and subsequent well‐being in older breast cancer survivors: Longitudinal findings from the Thinking and Living with Cancer Studyagingbreast cancercancercancer survivorscognitive functiononcologyquality of life...
This single-arm Simon’s two-stage phase II trial was conducted at the Fudan University Shanghai Cancer Center. Patients with advanced or recurrent endometrial cancer who had failed at least one prior systemic therapy were screened for potential participation. Eligible patients were treated with intra...
Elucidating Pretreatment Cognitive Impairment in Breast Cancer Patients: The Impact of Cancer-Related Post-Traumatic Stress Purpose: To determine if older patients with breast cancer have cognitive impairment before systemic therapy. Patients and methods: Participants were patie... K Hermelink,V Voigt,...
Association of Kaposi's sarcoma and prior immunosuppressive therapy: a 5-year material of Kaposi's sarcoma in Norway. Cancer 1978, 42, 2626–30.Klepp O, Dahl O, Stenwig JT : Association of Kaposi’s sarcoma and prior immunosuppressive therapy: a 5-year material of Kaposi’s sarc...
To identify needs of metastatic breast cancer patients prior to starting a new systemic treatment. Methods Fifty patients with newly diagnosed, recurrent, or progressive metastatic breast cancer completed an electronic survey which included patient-reported outcome measures of function (PROMIS Cancer Functio...
Patients were asked to report, for example, their cancer diagnosis and stage, the PA-subjected intervention (from a 13-reponse list that included Oral Chemotherapy, Targeted Therapy, Hospital Stays and Supportive Medications), the time (in weeks) PA delayed treatment and how PA affected their ...
A total of 50 Gy of irradiation to the pancreatic tail and splenic hilum was carried out as local therapy for pancreatic cancer. Splenic irradiation was also expected to reverse liver cirrhosis-related thrombocytopenia, which was making systemic chemotherapy difficult to administer in this patient. ...
Treatment Patterns and Attrition With Lines of Therapy for Advanced Urothelial Carcinoma in the US Key Points: Question: What are the current treatment patterns and attrition rates in patients with advanced urothelial cancer? Findings: In this cohort stu... V Mathew Thomas,Y Jo,N Tripathi,... ...
(ADT) significantly reduces the risk of radiographic progression-free survival (rPFS) and improves overall survival in metastatic hormone-sensitive prostate cancer (mHSPC), the efficacy in clinically relevant subgroups of patients based on prior local and systemic therapy, disease volume, and risk has...
Alternating systemic and hepatic artery infusion therapy for resected liver metastases from colorectal cancer: a North Central Cancer Treatment Group (NCCTG)/ National Surgical Adjuvant Breast and Bowel Project (NSABP) phase II intergrou... PURPOSE Prior trials have shown that surgery followed by hepa...